EC Number | Application | Comment | Organism |
---|---|---|---|
2.7.1.1 | medicine | TbHK1 is a valid therapeutic target while identifying a potential molecular target of the anti-trypanosomal agent lonidamine | Trypanosoma brucei |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.1.1 | lonidamine | lonidamine is toxic to cultured bloodstream form parasites and procyclic form parasites. Overexpression of TbHK1 protects procyclic forms from lonidamine | Trypanosoma brucei |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.1.1 | Trypanosoma brucei | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.1.1 | bloodstream form | TbHK1 is essential to the bloodstream form. Silencing the gene for 4 days reduces cellular hexokinase about 60% and leads to parasite death | Trypanosoma brucei | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.1.1 | hexokinase 1 | - |
Trypanosoma brucei |
2.7.1.1 | TbHK1 | - |
Trypanosoma brucei |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.7.1.1 | 0.85 | - |
recombinant enzyme | Trypanosoma brucei | lonidamine |